February 16, 2023
The end of the public health emergency (PHE) means that most of the mandates under the current PHE for COVID-19 end on May 11, 2023. This could result in a loss of coverage for some people, or increased costs associated with COVID-19 for others. The end of the PHE also means that the federal government is no longer purchasing COVID-19 vaccines for the public. That means that public, or commercial, pricing will now apply for vaccines and treatments. We don’t yet know the actual commercial price but have seen reports indicating a cost for the vaccines between $82 to $130 per shot. The monoclonal antibody treatment supply, also purchased by the federal government, will remain at no cost to consumers until the federal supply runs out. We don’t yet know any commercial pricing for treatments.
Our COVID-19 work group is following this issue closely to develop our plan and communicate additional details about the gradual ending of COVID-19-era rules and requirements as that information becomes available. Our COVID-19 FAQ remains the best place to get current information about COVID-19 test and treatment coverage, as well as the policies and programs covered under the PHE.
Employer – COVID FAQ: https://www.premera.com/wa/employer/coronavirus-faq/
Member – COVID Information page: https://www.premera.com/visitor/outbreaks